Author: Reuters

LONDON (Reuters) – People in Britain are at their happiest at the ages of 16 and 70, according to an analysis of UK national statistics published on Wednesday. Teenagers score higher than young adults in their 20s on every...

ISTANBUL (Reuters) – Turkey increased on Wednesday the fixed exchange rate by 26.4 percent for pharmaceutical products that are imported, Health Minister Fahrettin Koca was reported as saying by broadcaster NTV. The...

SOFIA (Reuters) – Bulgaria has confirmed a new case of African swine fever in a wild boar near in the northeastern town of Devnya, the national food safety authority said on Wednesday. African swine fever is a highly...

By Linda Carroll (Reuters Health) – It looks like your mother was right: when you’ve got a cold, sleep may be the best medicine. German researchers have discovered one way sleep improves the body’s ability to...

By Lisa Rapaport (Reuters Health) – Even relatively healthy heart failure patients may still be more likely to die after surgery than people with healthier hearts, a U.S. study suggests. For heart failure patients with...

By Linda Carroll (Reuters Health) – Over the last three decades, improved screening and treatments may have kept hundreds of thousands of women from dying of breast cancer, computer simulations suggest. Depending on the...

(Reuters) – Mylan NV on Tuesday priced its generic version of GlaxoSmithKline’s blockbuster asthma treatment Advair 70 percent lower than the branded medicine. The treatment, the first generic of Advair, is approved...

(Reuters) – Generic competitors to British drugmaker Indivior Plc’s blockbuster opioid addiction treatment are on course to launch sales next week after the firm’s attempt to stay a U.S. District court...

By Lisa Rapaport (Reuters Health) – Roughly in six U.S. kids have at least one mental health disorder, and only about half of them receive treatment from a mental health professional, a new study suggests. Nationwide, an...

By Lisa Rapaport (Reuters Health) – Roughly 45 percent of Americans under 65 who have cardiovascular disease experience financial hardships from medical bills, a U.S. study suggests. And, almost one in five of them...

NEW YORK (Reuters) – Catalyst Pharmaceuticals Inc said on Monday that it expects its drug for a rare disease, which had long been available to patients for free, will cost more than $300,000 per year including rebates to...